89 related articles for article (PubMed ID: 9038620)
1. Oestrogen and progesterone receptors in gastrointestinal cancer cell lines.
Jacobs E; Watson SA; Hardcastle JD; Robertson JF
Eur J Cancer; 1996 Dec; 32A(13):2348-53. PubMed ID: 9038620
[TBL] [Abstract][Full Text] [Related]
2. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone.
Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A
Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
[TBL] [Abstract][Full Text] [Related]
4. Comparison of enzyme immunoassay and dextran-coated charcoal techniques for progesterone receptor determination in human breast cancer cytosols.
Foekens JA; Portengen H; van Driel J; van Putten WL; Haije WG; Klijn JG
J Steroid Biochem; 1988 Jun; 29(6):571-4. PubMed ID: 3290577
[TBL] [Abstract][Full Text] [Related]
5. [Inconsistency in quantitation of estrogen receptor and progesterone receptor with dextran charcoal method and enzyme immunoassay].
Morimoto K; Hasuma T; Koh M; Ohtani S; Kinoshita H
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1597-605. PubMed ID: 12355945
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evaluation of estrogen and progesterone receptors in paraffin-embedded, formalin-fixed endometrial tissues: comparison with enzyme immunoassay and immunohistochemical analysis of frozen tissue.
Ravn V; Havsteen H; Thorpe SM
Mod Pathol; 1998 Aug; 11(8):709-15. PubMed ID: 9720497
[TBL] [Abstract][Full Text] [Related]
7. Discrepancies between antibody (EIA) and saturation analysis of oestrogen receptor content in breast tumour samples.
Marsigliante S; Puddefoot JR; Barker S; Gledhill J; Vinson GP
J Steroid Biochem Mol Biol; 1990 Dec; 37(5):643-8. PubMed ID: 2278849
[TBL] [Abstract][Full Text] [Related]
8. Transcriptionally active non-ligand binding oestrogen receptors in breast cancer.
Marsigliante S; Greco S; Biscozzo L; Barker S; Baker V; Giuseppe L; Vinson GP; Storelli C
Cancer Lett; 1992 Oct; 66(3):183-91. PubMed ID: 1451100
[TBL] [Abstract][Full Text] [Related]
9. The nontransformed progesterone and estrogen receptors in gastric cancer.
Wu CW; Chang HM; Kao HL; Lui WY; P'eng FK; Chi CW
Gastroenterology; 1992 May; 102(5):1639-46. PubMed ID: 1373695
[TBL] [Abstract][Full Text] [Related]
10. Use of serial semithin frozen sections to evaluate the co-localization of estrogen receptors and progesterone receptors in cells of breast cancer tissues.
Kudo A; Fukushima H; Kawakami H; Matsuda M; Goya T; Hirano H
J Histochem Cytochem; 1996 Jun; 44(6):615-20. PubMed ID: 8666746
[TBL] [Abstract][Full Text] [Related]
11. Oestrogen receptor negative-progesterone receptor positive phenotype in 1,211 breast tumours.
Pichon MF; Milgrom E
Br J Cancer; 1992 Jun; 65(6):895-7. PubMed ID: 1616860
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic Characteristics of Oestrogen Receptor-Positive/Progesterone Receptor-Negative/Her2-Negative Breast Cancer According to a Novel Definition of Negative Progesterone Receptor Status: A Large Population-Based Study from China.
Li AQ; Zhou SL; Li M; Xu Y; Shui RH; Yu BH; Yang WT
PLoS One; 2015; 10(5):e0125067. PubMed ID: 25938238
[TBL] [Abstract][Full Text] [Related]
13. Progesterone receptor: stability studies and correlation between steroid binding assay and enzyme immunoassay.
Wu JT; Wilson LW
Clin Chem; 1988 Oct; 34(10):1987-91. PubMed ID: 3048778
[TBL] [Abstract][Full Text] [Related]
14. Oestrogen and progesterone receptor estimation by enzyme-immunoassay on tissues removed before and after a modified radical mastectomy.
Vyas JJ; Redkar AA; Kabre SS; Mittra I
Eur J Surg Oncol; 1993 Aug; 19(4):368-71. PubMed ID: 8359284
[TBL] [Abstract][Full Text] [Related]
15. Comparison of monoclonal antibodies and tritiated ligands for estrogen receptor assays in 241 breast cancer cytosols.
Goussard J; Lechevrel C; Martin PM; Roussel G
Cancer Res; 1986 Aug; 46(8 Suppl):4282s-4287s. PubMed ID: 2425945
[TBL] [Abstract][Full Text] [Related]
16. Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay.
Saccani Jotti G; Johnston SR; Salter J; Detre S; Dowsett M
J Clin Pathol; 1994 Oct; 47(10):900-5. PubMed ID: 7962603
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and progesterone receptors in gastric and colorectal cancer.
Oshima CT; Wonraht DR; Catarino RM; Mattos D; Forones NM
Hepatogastroenterology; 1999; 46(30):3155-8. PubMed ID: 10626177
[TBL] [Abstract][Full Text] [Related]
18. A comparison between radioligand and immunohistochemical assay of hormone receptors in primary breast cancer.
Charalambous D; Kitchen PR; Stillwell RG; Smart PJ; Rode J
Aust N Z J Surg; 1993 Aug; 63(8):637-41. PubMed ID: 8338483
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of hormone receptor and hormone-regulated protein expression in phyllodes tumour: comparison with fibroadenoma.
Umekita Y; Yoshida H
Virchows Arch; 1998 Oct; 433(4):311-4. PubMed ID: 9808432
[TBL] [Abstract][Full Text] [Related]
20. Sex hormone-receptor-negative tumors have a higher proliferative activity than sex hormone-receptor-positive tumors in human adenocarcinomas of the gastrointestinal tract.
Korenaga D; Orita H; Okuyama T; Kinoshita J; Maekawa S; Ikeda T; Sugimachi K
Surg Today; 1998; 28(10):1007-14. PubMed ID: 9786571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
